Jennison Associates LLC Neurocrine Biosciences Inc Transaction History
Jennison Associates LLC
- $155 Billion
- Q2 2024
A detailed history of Jennison Associates LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Jennison Associates LLC holds 499,323 shares of NBIX stock, worth $58.9 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
499,323
Previous 345,446
44.54%
Holding current value
$58.9 Million
Previous $47.6 Million
44.28%
% of portfolio
0.04%
Previous 0.03%
Shares
22 transactions
Others Institutions Holding NBIX
# of Institutions
636Shares Held
95.2MCall Options Held
661KPut Options Held
227K-
Black Rock Inc. New York, NY14.2MShares$1.68 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$1.19 Billion0.03% of portfolio
-
State Street Corp Boston, MA4.61MShares$544 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.47MShares$291 Million0.6% of portfolio
-
Jpmorgan Chase & CO New York, NY2.36MShares$279 Million0.03% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $11.3B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...